{
  "abstract": "Aztreonam-avibactam (ATM-AVI) is a promising therapeutic for New Delhi metallo-β-lactamase-producing Enterobacterales (NDM-E) infections. We evaluated the performance of disk diffusion and gradient diffusion methods compared with reference broth microdilution (BMD) for ATM-AVI susceptibility testing. A total of 245 non-duplicate NDM-E isolates were included, collected from unique patients at hospitals in Chile and the United States between 2022 and 2024. Nine ATM-AVI non-susceptible isolates from a separate collection were added to enrich for resistant isolates, yielding a total of 254 isolates. Reference BMD was performed according to Clinical and Laboratory Standards Institute (CLSI) criteria. ATM-AVI disk diffusion and two gradient diffusion methods (ETEST and MIC Test Strip) were evaluated against BMD using categorical agreement, essential agreement, and CLSI-defined error rates. All 245 NDM-E isolates were susceptible to ATM-AVI (MIC ≤4/4 µg/mL), with MIC₅₀/₉₀ values of 0.25/4 and 1/4 µg/mL, respectively. The collection consisted of Klebsiella pneumoniae (71%), Enterobacter cloacae complex (21%), and Escherichia coli (8%). Predominant NDM alleles included blaNDM-1 and blaNDM-7. Disk diffusion demonstrated 98% categorical agreement (250/254), with four minor errors. Both gradient diffusion methods achieved 99% categorical agreement (252/254), with no very major or major errors and two minor errors. Essential agreement was 67% for ETEST and 85% for MIC Test Strip; both methods tended to underestimate ATM-AVI MICs relative to BMD. ATM-AVI demonstrated robust in vitro activity against a contemporary NDM-E cohort. Disk and gradient diffusion methods are practical alternatives to BMD for clinical laboratories.",
  "abstract_shown": true,
  "affiliations": [
    "Genomics & Resistant Microbes Group (GeRM), Instituto de Ciencias e Innovación en Medicina (ICIM), Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago, Chile",
    "Multidisciplinary Initiative for Collaborative Research on Bacterial Resistance (MICROB-R), Santiago, Chile",
    "Surveillance, Epidemiology, and New Technologies for Infectious Emerging Threats (SENTINET), Santiago, Chile",
    "UC Irvine School of Medicine, Irvine, California, USA",
    "Hospital Padre Hurtado, Santiago, Chile",
    "Pontificia Universidad Católica de Chile, Santiago, Chile",
    "Hospital La Florida, Santiago, Chile",
    "Hospital Regional de Puerto Montt, Universidad San Sebastián, Puerto Montt, Chile",
    "Hospital Dipreca, Santiago, Chile",
    "The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA"
  ],
  "article_type": "research article",
  "arxiv": null,
  "author_total": 15,
  "authors": [
    {
      "affs": [
        0,
        1,
        2
      ],
      "name": "Lina Rivas",
      "orcid": "0000-0002-8075-9812"
    },
    {
      "affs": [
        0,
        1,
        2
      ],
      "name": "Lorena Díaz",
      "orcid": "0000-0002-9783-1956"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Valeria Quiroz"
    },
    {
      "affs": [
        0,
        1,
        2
      ],
      "name": "Jose R. W. Martinez",
      "orcid": "0000-0002-9733-1118"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Camila Solar",
      "orcid": "0000-0002-6191-4792"
    },
    {
      "affs": [
        3
      ],
      "name": "Ayesha Khan"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Katherine Soto"
    },
    {
      "affs": [
        4
      ],
      "name": "Pamela Rojas Soto"
    },
    {
      "affs": [
        5,
        6
      ],
      "name": "Maria-Paz Acuña"
    },
    {
      "affs": [
        7
      ],
      "name": "María L. Rioseco"
    },
    {
      "affs": [
        8
      ],
      "name": "Margareta Mühlhauser"
    },
    {
      "affs": [
        9
      ],
      "name": "Yehudit Bergman"
    },
    {
      "affs": [
        1,
        5
      ],
      "name": "Patricia García"
    },
    {
      "affs": [
        0,
        1,
        2
      ],
      "name": "José M. Munita"
    },
    {
      "affs": [
        9
      ],
      "name": "Pranita D. Tamma",
      "orcid": "0000-0002-4143-6324"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/09qyc9n1ferj0.bib",
  "cited_by": 0,
  "doi": "10.1128/jcm.00797-26",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13753813/",
  "id": "09qyc9n1ferj0",
  "issns": [
    "0095-1137",
    "1098-660X"
  ],
  "landing_url": "https://doi.org/10.1128/jcm.00797-26",
  "language": "en",
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Bacteriology"
    ],
    [
      "openalex",
      "2726|Antibiotic Resistance in Bacteria"
    ]
  ],
  "openalex": "W7221553105",
  "pdf_url": null,
  "pmcid": "PMC13753813",
  "pmid": "42861991",
  "published": "2026-10-12",
  "publisher": "American Society for Microbiology (ASM)",
  "ris": "https://research.draconitic.com/paper/09qyc9n1ferj0.ris",
  "sources": [
    {
      "first_seen": "2026-11-15T12:22:50Z",
      "native_id": "PMC13753813",
      "source": "pmc",
      "url": "https://doi.org/10.1128/jcm.00797-26"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2726|Antibiotic Resistance in Bacteria",
      "subfield": "infectious-disease"
    }
  ],
  "title": "Comparison of antimicrobial susceptibility testing methods for aztreonam-avibactam against NDM-producing Enterobacterales clinical isolates",
  "title_text": "Comparison of antimicrobial susceptibility testing methods for aztreonam-avibactam against NDM-producing Enterobacterales clinical isolates",
  "type": "peer-reviewed",
  "updated_at": "2026-11-15T12:22:50Z",
  "url": "https://research.draconitic.com/paper/09qyc9n1ferj0",
  "venue": "Journal of Clinical Microbiology",
  "versions": []
}